Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...51525354555657585960...
CompanyDrug NameStatusIndication Group
Bristol-Myers Squibb ATRIPLA Approved in USA and CanadaAnti-infectives for systemic use
Biovail Ativan ODT N/ANervous system
Fresenius Biotech ATG-Fresenius S in Phase IIAntineoplastic & immunomodulating agents
AstraZeneca Atacand Approved in USA and EUCardiovascular system
AstraZeneca Atacand in Phase IIICardiovascular system
Schering-Plough Asmanex Submitted for approval in JapanRespiratory system
Novo Nordisk ASIS Active Site Inhibited Seven or FFR-FVIIa in Phase IIRespiratory system
GlaxoSmithKline ARRANON Approved in USAAntineoplastic & immunomodulating agents
GlaxoSmithKline ARRANON Approved in USAAntineoplastic & immunomodulating agents
Antigenics Aroplatin in Phase IAntineoplastic & immunomodulating agents
Pfizer Aromasin Approved in EU and USAAntineoplastic & immunomodulating agents
GlaxoSmithKline Arixtra Approved in USA and EUCardiovascular system
Schering-Plough Arixtra in Phase IIICardiovascular system
GlaxoSmithKline Arixtra Approved in USA and EUCardiovascular system
AstraZeneca Arimidex in Phase IIIAntineoplastic & immunomodulating agents
GlaxoSmithKline Ariflo Approved in USA and EURespiratory system
Pharmaxis Aridol accomplished Phase IIIRespiratory system
Eisai Aricept Approved in USANervous system
Eisai Aricept discontinuedNervous system
Merck Arcoxia Approved in USA and EUMusculoskeletal system
...51525354555657585960...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.